Asmer MS, Kirkham J, Newton H, Ismail Z, Elbayoumi H, Leung RH, et al
Mughal W, Kirshenbaum LA
doi: 10.1056/NEJMoa1901981 Summary Keywords demyelinating diseases, astrocyte, glia, neuroinflammation, multiple sclerosis, NMOSD, synaptopathy, disease modifying therapies Citation Coutinho Costa VG, Arajo SE-S, Alves-Leon SV and Gomes FCA (2023) Central nervous system demyelinating diseases: glial cells at the hub of pathology
Researching muscle-supporting peptides can complement this training approach for those looking at additional options
In view of its importance, there is a need to develop an in silico method for predicting 1) half-life of peptides as well as 2) prediction of mutations required in a peptide, in order to increase its intestinal half-life